suPARnostic® eliminates doubt and supports your clinical decisions to discharge or admit patients based on prognostic evidence.

Discharge more patients

suPAR is a prognostic biomarker that reflects the extent of activation of the immune system non-specific to any individual disease.

Implementing suPARnostic® in acute clinical care allows you to identify 34% * more patients who can be discharged. This reduces crowding and leads to lower healthcare costs.

A low suPAR level (under 4 ng/ml) indicates a good prognosis and supports the decision to discharge the patient.

A high suPAR level (over 6 ng/ml) indicates the presence, progression, and severity of disease, organ damage, mortality risk and supports further clinical attention.

* Ref. 2016 EMJ Rasmussen et al.

How to interpret suPAR results

Documented by 700+ peer-reviewed publications

Here you can find a summary of the research done on suPAR within different disease areas.

Drawing of people disapearing

Improve patient outcomes and lower healthcare costs

Prognostic, data-based risk stratification increases the efficiency of the emergency department and improves patient outcomes.

Implementing suPARnostic® shortens the average patient length-of-stay by 6%* per patient and reduces crowding and hospital costs.*

* Schultz et al. Disease Markers, 2019, 10;1-8

The key challenge for the emergency department is to identify ill patients faster, make diagnoses faster, find the right specialist faster and initiate the right treatment faster.

– MD, Chief Physician Inger Søndergaard, Herlev Hospital, Copenhagen

Early anakinra treatment of COVID-19 patients guided by suPAR saves lives

Get our whitepaper about the study results and read more about how an early start of anakinra treatment guided by suPAR provides 2.78 times better improvement of overall clinical status in moderate and severe COVID-19 pneumonia.


published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex


For Automated Systems

Photo of suPARnostic® ELISA


Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates